Literature DB >> 3548406

Expression of Ha-ras oncogene p21 protein in relation to the cell cycle of cultured human tumor cells.

B Czerniak, F Herz, R P Wersto, L G Koss.   

Abstract

It has been postulated that the expression of the product (p21) encoded by the ras genes may have a role in cell cycle events. Simultaneous multiparameter flow cytometry was used to measure the p21 content in relation to the cell cycle of several cancer cell lines of human origin. These studies revealed that p21 levels rise during the G1 phase of the cycle and remain approximately constant as cells traverse the S and G2 + M phases. The threshold level of p21 expression of S phase cells was used to divide the G1 cell population into cells with low (G1A) and high (G1B) p21 content. The p21 levels of G1B cells were approximately ten times higher than those of G1A cells. The validity of this subdivision was confirmed by synchronous measurements of RNA content and p21. Cells with low RNA content, hence in early part of G1 phase of the cell cycle, expressed low levels of p21, and cells with higher RNA content expressed higher levels of p21. These observations suggest that the levels of p21 are much lower at the onset of the cell cycle than at its end; hence a drop in p21 expression is likely to occur during or immediately after mitotic division.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3548406      PMCID: PMC1899652     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  35 in total

1.  Induction of c-fos gene and protein by growth factors precedes activation of c-myc.

Authors:  R Müller; R Bravo; J Burckhardt; T Curran
Journal:  Nature       Date:  1984 Dec 20-1985 Jan 2       Impact factor: 49.962

Review 2.  Oncogenes and cancer: the p21 ras genes.

Authors:  T Y Shih; M O Weeks
Journal:  Cancer Invest       Date:  1984       Impact factor: 2.176

3.  Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver.

Authors:  M Goyette; C J Petropoulos; P R Shank; N Fausto
Journal:  Mol Cell Biol       Date:  1984-08       Impact factor: 4.272

4.  Microinjection of the oncogene form of the human H-ras (T-24) protein results in rapid proliferation of quiescent cells.

Authors:  J R Feramisco; M Gross; T Kamata; M Rosenberg; R W Sweet
Journal:  Cell       Date:  1984-08       Impact factor: 41.582

5.  Expression of Ca antigen in relation to cell cycle in cultured human tumor cells.

Authors:  B Czerniak; Z Darzynkiewicz; L Staiano-Coico; F Herz; L G Koss
Journal:  Cancer Res       Date:  1984-10       Impact factor: 12.701

6.  Transformation of NIH 3T3 cells by microinjection of Ha-ras p21 protein.

Authors:  D W Stacey; H F Kung
Journal:  Nature       Date:  1984 Aug 9-15       Impact factor: 49.962

7.  Comparative biochemical properties of normal and activated human ras p21 protein.

Authors:  J P McGrath; D J Capon; D V Goeddel; A D Levinson
Journal:  Nature       Date:  1984 Aug 23-29       Impact factor: 49.962

8.  The product of ras is a GTPase and the T24 oncogenic mutant is deficient in this activity.

Authors:  R W Sweet; S Yokoyama; T Kamata; J R Feramisco; M Rosenberg; M Gross
Journal:  Nature       Date:  1984 Sep 20-26       Impact factor: 49.962

9.  Monoclonal antibodies define differential ras gene expression in malignant and benign colonic diseases.

Authors:  A Thor; P Horan Hand; D Wunderlich; A Caruso; R Muraro; J Schlom
Journal:  Nature       Date:  1984 Oct 11-17       Impact factor: 49.962

10.  Activation of ras genes in human tumors does not affect localization, modification, or nucleotide binding properties of p21.

Authors:  T Finkel; C J Der; G M Cooper
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

View more
  1 in total

1.  Asymmetric distribution of oncogene products at mitosis.

Authors:  B Czerniak; F Herz; R P Wersto; L G Koss
Journal:  Proc Natl Acad Sci U S A       Date:  1992-06-01       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.